PrescriptionGiant is a FREE prescription savings program that can save you up to 75% on your prescriptions with or without insurance!

Talimogene Laherparepvec Injection

Actual product appearance may differ slightly.

Click the CARD below to print or take a screenshot on your mobile phone or tablet. There is no need to download another app!

If you would like to personalize your card enter your full name in the member name field below the card at this link and click the Update button.

Why is this medication prescribed?

Talimogene laherparepvec, sold under the brand name Imlygic, is an oncolytic virus therapy used in the treatment of melanoma, a type of skin cancer. It is specifically indicated for the treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery.

How should this medicine be used?

Here’s how Talimogene Laherparepvec Injection is generally used:

  • Administration: Talimogene laherparepvec is administered directly into the melanoma lesions through injection.
  • Treatment Schedule: The treatment is typically administered initially with a series of injections, followed by additional injections at regular intervals. The specific schedule may vary depending on the individual patient and the healthcare provider’s recommendations.
  • Monitoring: During the treatment, healthcare professionals will monitor the patient for any potential side effects or reactions. The patient’s overall health and response to the therapy will be assessed regularly.

It’s important to note that the usage of Talimogene laherparepvec is determined by a healthcare professional who will consider the patient’s medical history, the extent of the disease, and other relevant factors. Patients should follow their healthcare provider’s instructions and report any side effects or concerns promptly.

Always consult with your healthcare provider for specific information tailored to your medical condition and needs.

Other uses for this medicine

Talimogene laherparepvec (Imlygic) is primarily approved for the treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery. Its use for other conditions may not be approved or widely established. Always consult with a healthcare professional for the most current and accurate information, as there may have been developments or new indications since last update.

What special precautions should I follow?

Regarding special precautions for Talimogene Laherparepvec Injection, it’s essential to follow your healthcare provider’s advice, and you should inform them about your medical history, ongoing medications, and any allergies. Here are some general precautions that might be applicable:

  • Infection Control: Talimogene laherparepvec is a modified herpes simplex virus, and precautions should be taken to avoid potential transmission of the virus to others. Patients should be advised to avoid close contact, especially with individuals who have weakened immune systems or pregnant women.
  • Monitoring for Side Effects: Regular monitoring for potential side effects, such as flu-like symptoms, injection site reactions, or other adverse events, is important. Report any unusual or severe reactions to your healthcare provider.
  • Immune System Function: Talimogene laherparepvec works by stimulating the immune system. Inform your healthcare provider about any conditions that may affect your immune system, as the therapy’s effectiveness and safety could be influenced by immune system status.
  • Pregnancy and Breastfeeding: The safety of Talimogene laherparepvec during pregnancy or breastfeeding is not well-established. Discuss with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
  • Other Medications: Inform your healthcare provider about all the medications, including over-the-counter drugs, vitamins, and supplements, that you are taking. Certain medications may interact with Talimogene laherparepvec.

It’s crucial to have open communication with your healthcare team, and they will provide you with specific guidelines and precautions based on your individual health situation. Always follow their instructions and report any concerns promptly.

What special dietary instructions should I follow?

There are generally no specific dietary restrictions associated with Talimogene laherparepvec. However, it’s essential to maintain a balanced and healthy diet to support overall well-being during cancer treatment. If you have specific dietary concerns or restrictions, discuss them with your healthcare provider or a registered dietitian.

What should I do if I forget a dose?

Talimogene laherparepvec is typically administered by healthcare professionals, and the treatment schedule is carefully planned. If you miss an appointment for your injection, contact your healthcare provider as soon as possible to reschedule. It’s crucial to adhere to the recommended treatment schedule for the best possible outcomes. Do not attempt to administer the injection yourself or adjust the dosage without consulting your healthcare team.

What side effects can this medication cause?

Talimogene laherparepvec (Imlygic) may cause side effects, and the severity and occurrence can vary from person to person. Common side effects are often related to the injection site and the body’s immune response. Here are some potential side effects associated with Talimogene laherparepvec:

  • Injection Site Reactions: These are the most common side effects and may include pain, redness, swelling, bruising, or itching at the injection site. These reactions are usually temporary and resolve on their own.
  • Flu-Like Symptoms: Patients may experience flu-like symptoms such as fever, chills, fatigue, and muscle aches. These symptoms are generally mild to moderate and tend to improve over time.
  • Nausea and Vomiting: Some patients may experience nausea and vomiting as a side effect of Talimogene laherparepvec.
  • Fatigue: Fatigue or tiredness may occur as a result of the body’s immune response to the treatment.
  • Fever: A mild increase in body temperature may occur.
  • Headache: Some patients may experience headaches during or after treatment.
  • Dizziness: Dizziness or lightheadedness may occur in some individuals.
  • Infections: Since Talimogene laherparepvec is a live virus, there is a risk of developing infections. It’s important to inform healthcare providers about any signs of infection, such as fever or persistent pain at the injection site.

It’s crucial to report any unusual or severe side effects to your healthcare provider promptly. Additionally, individuals with weakened immune systems or those taking immunosuppressive medications may be more susceptible to certain side effects.

This list is not exhaustive, and the side effects can vary. Always consult with your healthcare provider for personalized information based on your health condition and any specific concerns you may have.

What should I know about storage and disposal of this medication?

Storage and Disposal of Talimogene Laherparepvec Injection:

  • Storage: Talimogene laherparepvec is usually stored in a healthcare setting, and the vials are kept refrigerated. Follow the storage instructions provided by your healthcare provider or the facility administering the treatment.
  • Disposal: Proper disposal of unused or expired medication should be carried out according to local regulations. Healthcare providers or facilities that administer Talimogene laherparepvec are responsible for proper disposal procedures. Do not attempt to dispose of medical waste or unused medication on your own.

In case of emergency/overdose

In the case of an emergency or overdose, it’s crucial to seek immediate medical attention. The safety profile of Talimogene laherparepvec has been studied in clinical trials, but any unexpected reactions or complications should be reported to healthcare professionals as soon as possible.

What other information should I know?

  • Follow-Up Appointments: Regular follow-up appointments with your healthcare provider are essential during Talimogene laherparepvec treatment. These appointments allow for monitoring of your response to the therapy and the management of any potential side effects.
  • Informing Healthcare Providers: Keep your healthcare providers informed about your medical history, current medications (including prescription and over-the-counter drugs), and any changes in your health status.
  • Infection Control: Given that Talimogene laherparepvec is a live virus, patients should be cautious to avoid close contact with individuals who have weakened immune systems or are pregnant to prevent potential transmission.
  • Pregnancy and Breastfeeding: Inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. The safety of Talimogene laherparepvec during pregnancy or breastfeeding is not well-established.
  • Immune System Conditions: If you have conditions affecting your immune system, such as HIV or immunosuppressive medications, discuss this with your healthcare provider. These factors may influence the safety and efficacy of Talimogene laherparepvec.

Always follow your healthcare provider’s instructions and guidance. If you have specific concerns or questions about Talimogene laherparepvec, discuss them with your healthcare team for personalized advice.

Copyright © 2023